Literature DB >> 22918193

Monocyte function and trafficking in cardiovascular disease.

Evangelia Pardali1, Johannes Waltenberger.   

Abstract

Monocytes are key effectors of the immune homeostasis and play a crucial role in (vascular) injury repair. Despite their role in immune defense and tissue repair mechanisms, monocytes are also involved in several pathological conditions such as autoimmune and cardiovascular diseases as well as cancer. This suggests that monocytes can be used as diagnostic and as therapeutic targets. A better understanding and characterisation of monocytes and their function in both physiological and pathological situations is thus of great interest. This review focuses on recent advances on the role of monocytes in cardiovascular diseases and describes the value of monocytes as either disease marker or therapeutic target for (cardio)vascular diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22918193     DOI: 10.1160/TH12-04-0276

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Building solutions for cardiovascular disease in women.

Authors:  Micheline M Resende; Doris A Taylor
Journal:  Tex Heart Inst J       Date:  2013

2.  Measurement science in the circulatory system.

Authors:  Casey M Jones; Sandra M Baker-Groberg; Flor A Cianchetti; Jeremy J Glynn; Laura D Healy; Wai Yan Lam; Jonathan W Nelson; Diana C Parrish; Kevin G Phillips; Devon E Scott-Drechsel; Ian J Tagge; Jaime E Zelaya; Monica T Hinds; Owen J T McCarty
Journal:  Cell Mol Bioeng       Date:  2014-03       Impact factor: 2.321

3.  Mitochondria in monocytes and macrophages-implications for translational and basic research.

Authors:  Saranya Ravi; Tanecia Mitchell; Philip Kramer; Balu Chacko; Victor M Darley-Usmar
Journal:  Int J Biochem Cell Biol       Date:  2014-05-23       Impact factor: 5.085

4.  Fluid shear stress upregulates placental growth factor in the vessel wall via NADPH oxidase 4.

Authors:  Nabil A Rashdan; Pamela G Lloyd
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

5.  Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitus.

Authors:  M Reijrink; J van Ark; C P H Lexis; L M Visser; M E Lodewijk; I C C van der Horst; C J Zeebregts; H van Goor; S C A de Jager; G Pasterkamp; B H R Wolffenbuttel; J L Hillebrands
Journal:  Cardiovasc Diabetol       Date:  2022-05-12       Impact factor: 8.949

Review 6.  Cardiovascular disease risk in an aging HIV population: not just a question of biology.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

7.  Cryopreservation of primary human monocytes does not negatively affect their functionality or their ability to be labelled with radionuclides: basis for molecular imaging and cell therapy.

Authors:  Evangelia Pardali; Timo Schmitz; Andreas Borgscheiper; Janette Iking; Lars Stegger; Johannes Waltenberger
Journal:  EJNMMI Res       Date:  2016-10-24       Impact factor: 3.138

8.  Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States.

Authors:  Ming Jiang; Jiaming Yang; Huayiyang Zou; Menghuan Li; Wei Sun; Xiangqing Kong
Journal:  Lipids Health Dis       Date:  2022-03-18       Impact factor: 3.876

9.  The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases.

Authors:  Yu-Jih Su; Chao Tung Chen; Nai-Wen Tsai; Chih-Cheng Huang; Hung-Chen Wang; Chia-Te Kung; Wei-Che Lin; Ben-Chung Cheng; Chih-Min Su; Sheng-Yuan Hsiao; Cheng-Hsien Lu
Journal:  Am J Mens Health       Date:  2017-09-13

10.  BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation.

Authors:  Evangelia Pardali; Lena-Maria Makowski; Merle Leffers; Andreas Borgscheiper; Johannes Waltenberger
Journal:  J Cell Mol Med       Date:  2018-08-13       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.